Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance
Go back to Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 225.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.92 | 52 Week High | $160.00 | |||
| Open | $225.92 | 52 Week Low | $95.80 | |||
| Day High | $225.92 | P/E | 41.99 | |||
| Day Low | $225.92 | EPS | $5.38 | |||
| Volume | 1,323 | |||||
